AstraZeneca Investors Rejoice After COPD Drug Performs in Phase IV Study Post author:Sam Post published:December 3, 2017 Post category:BioPharma Tudorza, also marketed as Eklira and Bretaris, is available in more than 50 countries. Source: BioSpace You Might Also Like Mitsubishi Tanabe Coughs Up $1.1 Billion Cash for This Parkinson's Biotech July 23, 2017 Veracyte To Expand Patient Access To The Afirma Gene Expression Classifier In Thyroid Cancer Diagnosis Through Agreement With Quest Diagnostics February 7, 2017 2 Bay Area Biotechs That Jumped While Its Peers Cratered February 6, 2018
Veracyte To Expand Patient Access To The Afirma Gene Expression Classifier In Thyroid Cancer Diagnosis Through Agreement With Quest Diagnostics February 7, 2017
